triazoles has been researched along with Carcinoma, Endometrioid in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, D; Lang, J; Shen, K; Yang, J; Zhou, H | 1 |
| Bellini, E; Berchuck, A; Bernasocchi, T; Bertoni, F; Bielski, CM; Broaddus, RR; Carney, ME; Carr, SA; Cascione, L; Catapano, CV; Civenni, G; El Tekle, G; Enchev, RI; Garraway, LA; Janouskova, H; Kryukov, GV; Losa, M; Moch, H; Mutch, DG; Napoli, S; Peter, M; Rinaldi, A; Schraml, P; Svinkina, T; Theurillat, JP; Udeshi, ND; Ulbricht, A; Wild, PJ; Winterhoff, BJN | 1 |
| Cho, SH; Jang, KS; Kim, YJ; Lee, WM | 1 |
| Figg, WD; Hussain, MM; Kohn, EC; Kotz, H; Minasian, L; Oliver, VK; Premkumar, A; Raggio, M; Reed, E; Sarosy, G; Steinberg, SM; Zhai, S | 1 |
1 review(s) available for triazoles and Carcinoma, Endometrioid
| Article | Year |
|---|---|
Collision of three histologically distinct endometrial cancers of the uterus.
Topics: Aged; Aromatase Inhibitors; Carcinoma, Endometrioid; Chemotherapy, Adjuvant; Cystadenocarcinoma, Papillary; Endometrial Neoplasms; Female; Humans; Hysterectomy; Immunohistochemistry; Keratins; Letrozole; Lymphatic Metastasis; Mixed Tumor, Mullerian; Nitriles; Triazoles; Tumor Suppressor Protein p53 | 2012 |
1 trial(s) available for triazoles and Carcinoma, Endometrioid
| Article | Year |
|---|---|
Phase II trial of carboxyamidotriazole in patients with relapsed epithelial ovarian cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers; Calcium Channel Blockers; Carcinoma, Endometrioid; Carcinoma, Papillary; Cystadenocarcinoma, Serous; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Salvage Therapy; Survival Rate; Treatment Outcome; Triazoles | 2003 |
2 other study(ies) available for triazoles and Carcinoma, Endometrioid
| Article | Year |
|---|---|
Gonadotropin-Releasing Hormone Agonist Combined With a Levonorgestrel-Releasing Intrauterine System or Letrozole for Fertility-Preserving Treatment of Endometrial Carcinoma and Complex Atypical Hyperplasia in Young Women.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Carcinoma, Endometrioid; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Gonadotropin-Releasing Hormone; Humans; Intrauterine Devices, Medicated; Letrozole; Levonorgestrel; Nitriles; Retrospective Studies; Triazoles; Young Adult | 2017 |
Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors.
Topics: Acetanilides; Adenocarcinoma, Clear Cell; Animals; Apoptosis; Azepines; Carcinoma, Endometrioid; Carcinosarcoma; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Chromatography, Liquid; Cullin Proteins; Drug Resistance, Neoplasm; Endometrial Neoplasms; Epigenesis, Genetic; Female; Heterocyclic Compounds, 3-Ring; Humans; Immunoblotting; Immunohistochemistry; Immunoprecipitation; Male; Mass Spectrometry; Mice, Nude; Molecular Targeted Therapy; Mutation; Neoplasm Transplantation; Neoplasms, Cystic, Mucinous, and Serous; Nuclear Proteins; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA-Binding Proteins; Transcription Factors; Triazoles; Ubiquitination | 2017 |